Tag: Update

Posted on

UPDATE 5-Amazon’s outlook disappoints as customer budgets stay tight

UPDATE 5-Amazon’s outlook disappoints as customer budgets stay tight

(Adds CEO remark on cloud, grocery businesses)

By Jeffrey Dastin and Tiyashi Datta

Feb 2 (Reuters) – Amazon.com Inc on Thursday reported its working income could slide to zero in the present-day quarter as personal savings from layoffs do not make up for the fiscal impression of consumers and cloud clients clamping down on spending.

And though Amazon’s getaway income defeat Wall Street’s expectations, the business believes product sales development in its very long-beneficial cloud company will gradual for the next several quarters, its chief fiscal officer informed reporters.

Shares fell 5{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996} in after-hours trade, erasing most of their 7{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996} get prior to the market’s close Thursday.

Building a rare appearance on Amazon’s quarterly phone with money analysts, Main Govt Andy Jassy said “nearly every enterprise” was treading thoroughly on cloud and other fees in mild of economic uncertainty.

“We are likely to support our clients discover a way to shell out fewer income,” he reported. “We are seeking to establish a established of associations in company that outlasts all of us.”

Facing high inflation and recession fears, Jassy has embarked on comprehensive price-slicing within Amazon as properly.

Previous month, the on the internet retailer mentioned more than 18,000 workforce specially in its commerce and human assets divisions would drop their jobs. It booked a $640 million severance cost in the fourth quarter, CFO Brian Olsavsky explained to reporters.

Amazon furthermore has scaled back or shut down entire companies like its virtual major care featuring for employers. It took yet another $720 million demand from closing or impairing assets of some grocery stores, among other items, believing it has nonetheless to discover the proper components in its extended-jogging supermarket bet.

“We are not likely to increase the actual physical New shops till we have that equation, with differentiation and economic benefit that we like, but we are optimistic that we are likely to obtain that in 2023,” Jassy explained.

Irrespective of this price-reducing, Amazon forecast it would earn among $ and $4 billion in working income this quarter, in comparison with $3.7 billion in the identical time period a 12 months prior and $4.04 billion that analysts have been expecting, according to research firm FactSet.

Olsavsky attributed this to profits growth easing in the cloud, as properly as models pouring cash into Amazon ads a lot more gradually now that the holiday shopping season is about. Retail demand is another element.

“We stay anxious as all people else is about the customer investing and … how folks will prioritize their budgets transferring forward,” he claimed.

Value Purchasing

An October sale to encourage early getaway buying on Amazon has assisted with retail earnings, to a issue.

The firm’s complete net revenue had been $149.2 billion in the fourth quarter, in comparison with analysts’ anticipations of $145.4 billion, according to IBES knowledge from Refinitiv.

Purchaser paying, having said that, shifted more to benefit makes in some categories and a better proportion of gross sales in property necessities, Olsavsky stated.

Desire in Europe and the United Kingdom was also harm by superior inflation and the Ukraine war, reducing international development rates, he stated.

Amazon has sought new revenue in the in the meantime. The business ideas to charge specific grocery delivery service fees for U.S. Prime associates, on major of the latest value hikes to join the loyalty system it has developed an add-on generic-drug subscription to draw in business as properly.

Continue to, its outlook is notably tied to the fortunes of its cloud-computing division.

Andrew Lipsman, an analyst at Insider Intelligence, termed slower expansion in cloud and advertisements “a drag on income heading ahead.”

Tech market executives, like at rival Microsoft Corp , have claimed economic uncertainty has prompted enterprises to rethink how substantially they’re keen to shell out on cloud.

Even though AWS is encouraging consumers navigate these kinds of terrain, it continue to has a wholesome offer flow and future commitments from shoppers, creating the enterprise optimistic, Amazon CFO Olsavsky reported.

But “details of weak point” in cloud incorporated money expert services as property finance loan volumes are down, and there has been a lot less trading in cryptocurrency, he mentioned.

For now, the division fell small of estimates of additional than $22 billion in fourth-quarter cloud gross sales. They improved 20{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996} to $21.4 billion. (Reporting by Jeffrey Dastin in San Francisco and Tiyashi Datta in Bengaluru Enhancing by Anil D’Silva, Aurora Ellis and Kenneth Maxwell)

Posted on

BlackRock MuniYield Quality Fund, Inc. (NYSE:MQY) Short Interest Update

BlackRock MuniYield Quality Fund, Inc. (NYSE:MQY) Short Interest Update

BlackRock MuniYield Top quality Fund, Inc. (NYSE:MQY – Get Rating) was the recipient of a substantial decrease in quick desire in the course of the thirty day period of December. As of December 15th, there was shorter interest totalling 41,400 shares, a drop of 18.{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996} from the November 30th whole of 50,500 shares. Dependent on an normal day-to-day trading quantity, of 296,500 shares, the short-interest ratio is presently .1 days.

Institutional Trading of BlackRock MuniYield Excellent Fund

Large traders have not too long ago bought and marketed shares of the inventory. ACG Prosperity bought a new stake in BlackRock MuniYield Top quality Fund through the 2nd quarter truly worth roughly $32,000. Cowa LLC obtained a new stake in BlackRock MuniYield High-quality Fund in the course of the 3rd quarter worthy of approximately $35,000. Captrust Fiscal Advisors procured a new stake in BlackRock MuniYield Top quality Fund all through the 2nd quarter worth close to $52,000. CWM LLC grew its posture in BlackRock MuniYield High quality Fund by 550.1{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996} through the 2nd quarter. CWM LLC now owns 4,635 shares of the monetary solutions provider’s inventory worth $59,000 immediately after purchasing an extra 3,922 shares during the last quarter. At last, IFP Advisors Inc grew its placement in BlackRock MuniYield Excellent Fund by 265.6{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996} all through the 3rd quarter. IFP Advisors Inc now owns 9,181 shares of the economic services provider’s stock worthy of $128,000 right after obtaining an extra 6,670 shares for the duration of the previous quarter.

BlackRock MuniYield Excellent Fund Inventory Down .6 {21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996}

Shares of BlackRock MuniYield Good quality Fund inventory traded down $.07 on Monday, achieving $11.60. The inventory had a trading volume of 6,240 shares, when compared to its normal quantity of 239,092. The organization has a 50 day moving regular price tag of $11.39 and a 200 working day going ordinary selling price of $11.96. BlackRock MuniYield High-quality Fund has a 1 calendar year reduced of $10.48 and a 1 12 months large of $16.18.

BlackRock MuniYield Quality Fund Improves Dividend

The enterprise also recently introduced a month to month dividend, which was paid on Friday, December 30th. Shareholders of history on Friday, December 16th ended up specified a dividend of $.048 per share. This signifies a $.58 annualized dividend and a generate of 4.96{21df340e03e388cc75c411746d1a214f72c176b221768b7ada42b4d751988996}. The ex-dividend day of this dividend was Thursday, December 15th. This is an enhance from BlackRock MuniYield Good quality Fund’s earlier regular monthly dividend of $.05.

BlackRock MuniYield Excellent Fund Corporation Profile

(Get Rating)

BlackRock MuniYield Quality Fund, Inc is a close ended fixed profits mutual fund launched by BlackRock, Inc It is managed by BlackRock Advisors, LLC. The fund invests in set earnings markets. It invests in lengthy-time period municipal obligations the curiosity on which is exempt from federal revenue taxes. The fund also invests in shorter-expression securities.

Proposed Tales

This immediate information warn was created by narrative science engineering and economical knowledge from MarketBeat in get to offer audience with the quickest and most accurate reporting. This story was reviewed by MarketBeat’s editorial crew prior to publication. Make sure you mail any concerns or remarks about this story to get hold of@marketbeat.com.

Right before you take into consideration BlackRock MuniYield Quality Fund, you can want to listen to this.

MarketBeat keeps observe of Wall Street’s top rated-rated and best executing study analysts and the shares they advocate to their clients on a day by day foundation. MarketBeat has identified the 5 shares that best analysts are quietly whispering to their purchasers to purchase now right before the broader current market catches on… and BlackRock MuniYield High quality Fund was not on the list.

Although BlackRock MuniYield Quality Fund at present has a “keep” score between analysts, major-rated analysts believe these five shares are greater purchases.

Look at The Five Shares Listed here

Posted on

Horizon Technology Finance Provides First Quarter 2022 Portfolio Update

Horizon Technology Finance Provides First Quarter 2022 Portfolio Update

– Horizon Platform Originates $132 Million of New Loans in Q1, Including $73 Million of New Loans for HRZN – 

– Horizon Platform Ends Quarter with Record Committed Backlog of $172 Million, Including $151 Million in HRZN Commitments –   

FARMINGTON, Conn., April 13, 2022 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“HRZN” or the “Company”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the first quarter ended March 31, 2022 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.

“We had a very productive start to 2022, closing $132 million of loans originated through our lending platform in the first quarter, including $73 million of loans for HRZN,” said Gerald A. Michaud, President of HTFM. “In addition, the Horizon Platform’s committed backlog grew to a record $172 million of debt investments, including $151 million in HRZN commitments, showcasing the strength of the Horizon brand to attract quality innovative and diverse companies. HRZN also received $12 million in loan prepayments during the quarter, providing additional and accelerated income and continuing to validate our predictive pricing strategy. With a robust backlog and an additional $165 million of new awards to go along with a significant pipeline of new investment opportunities, we believe the Horizon Platform and HRZN remain well positioned to continue growing and delivering additional value to HRZN’s shareholders.”

First Quarter 2022 Portfolio Update

Originations

During the first quarter of 2022, a total of $131.9 million of loans funded through the Horizon Platform, including 16 loans totaling $73.2 million funded by HRZN as follows:

  • $7.5 million to a new portfolio company, MyForest Foods Co., a producer of sustainable, meat alternative products using mycelium, or the roots of mushrooms.
  • $7.5 million to a new portfolio company, a software-enabled services provider focused on planning, migration, operation and automation of SAP in the cloud.
  • $7.5 million to a new portfolio company, a leader in indoor vertical farming.
  • $7.5 million to a new portfolio company, a developer of prescription digital diagnostic and therapeutic products focused on pediatric behavioral health conditions.
  • $7.5 million to a new portfolio company, a leading grower and marketer of fresh organic culinary herbs, providing sustainable, USDA-certified organic, regionally grown produce to retailers.
  • $5.5 million to an existing portfolio company, NextCar Holding Company, Inc. dba Autonomy, an online platform offering high quality new and used cars to consumers on a subscription basis.
  • $5.0 million to a new portfolio company, Aerobiotix, LLC, a manufacturer of air disinfection systems for medical, healthcare and community facilities that eliminate airborne pathogens to optimize indoor air quality.
  • $5.0 million to a new portfolio company, Secure Transfusion Services, Inc., an operator of commercial blood collection centers that source and distribute vital, in-demand blood components, such as platelets, to hospitals.
  • $5.0 million to an existing portfolio company, Castle Creek Biosciences, Inc., a developer of gene therapies for patients with rare and serious genetic diseases.
  • $5.0 million to an existing portfolio company, a medical data company improving healthcare outcomes with its proprietary smart medical devices.
  • $2.5 million to an existing portfolio company, Spineology, Inc., a developer of anatomy-conserving technology solutions for use in lumbar spinal fusion procedures.
  • $2.5 million to an existing portfolio company, Dropoff, Inc., a same-day delivery service for healthcare and other companies.
  • $2.5 million to an existing portfolio company, a builder of conservation memorial forests that offer sustainable alternatives to cemeteries.
  • $1.25 million to an existing portfolio company, Unagi, Inc., a developer of premium portable electric scooters that are offered for sale and on an affordable monthly subscription program.
  • $1.0 million to an existing portfolio company, Alula, Inc., a designer and manufacturer of security systems sold exclusively to professional distributors and dealers.
  • $0.4 million to an existing company, MacuLogix, Inc., a medical device company in the optometry and ophthalmology industry.

Liquidity Events

HRZN experienced liquidity events from two portfolio companies in the first quarter of 2022, including principal prepayments of $12.0 million, compared to $55.0 million of principal prepayments and $0.4 million of warrant and equity proceeds during the fourth quarter of 2021: 

  • In February, LiquiGlide, Inc. prepaid its outstanding principal balance of $2.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in the company.
  • In February, Quip NYC Inc. prepaid its outstanding principal balance of $10.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in the company.

Principal Payments Received

During the first quarter of 2022, HRZN received regularly scheduled principal payments on investments totaling $1.9 million, compared to regularly scheduled principal payments totaling $2.9 million during the fourth quarter of 2021.

Commitments

During the quarter ended March 31, 2022, HRZN closed new loan commitments totaling $100.4 million to 11 companies, compared to new loan commitments of $114.9 million to 10 companies in the fourth quarter of 2021. HTFM’s other managed funds, during the quarter, closed new loan commitments totaling $60.0 million of unfunded loan approvals and commitments.

Pipeline and Term Sheets

As of March 31, 2022, HRZN’s unfunded loan approvals and commitments (“Committed Backlog”) were $150.8 million to 20 companies. This compares to a Committed Backlog of $124.5 million to 23 companies as of December 31, 2021. HRZN’s portfolio companies have discretion whether to draw down such commitments and the right of a portfolio company to draw down its commitment is often subject to achievement of specific milestones and other conditions to borrowing.  Accordingly, there is no assurance that any or all of these transactions will be funded by HRZN. HTFM’s other managed funds ended the quarter with a total of $20.8 million of unfunded loan approvals and commitments.

During the quarter, HTFM received signed term sheets that are in the approval process, which may result in the Horizon Platform providing up to an aggregate of $165.0 million of new debt investments.  These opportunities are subject to underwriting conditions including, but not limited to, the completion of due diligence, negotiation of definitive documentation and investment committee approval, as well as compliance with HTFM’s allocation policy. Accordingly, there is no assurance that any or all of these transactions will be completed or funded by HRZN.

Warrant and Equity Portfolio

As of March 31, 2022, HRZN held a portfolio of warrant and equity positions in 85 portfolio companies, including 71 private companies, which provides the potential for future additional returns to HRZN’s shareholders.

About Horizon Technology Finance

Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of HRZN is to maximize its investment portfolio’s return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon Technology Finance Management LLC is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located in Portland, Maine, Austin, Texas, and Reston, Virginia. To learn more, please visit www.horizontechfinance.com.

Forward-Looking Statements

Statements included herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Horizon’s filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts:

Investor Relations:
ICR
Garrett Edson
[email protected]
(860) 284-6450

Media Relations:
ICR
Chris Gillick
[email protected]  
(646) 677-1819    

                                                                         

SOURCE Horizon Technology Finance Corporation

Posted on

Horizon Technology Finance Provides Fourth Quarter 2021 Portfolio Update

FARMINGTON, Conn., Jan. 12, 2022 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“HRZN” or the “Company”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the fourth quarter ended December 31, 2021 and an update on the lending platform (“Horizon Platform”) of Horizon Technology Finance Management LLC (“HTFM”), its investment adviser.

“We had another exceptional quarter, closing $118 million of loans originated through our lending platform, including $80 million of loans for HRZN,” said Gerald A. Michaud, President of HTFM. “For the year, the Horizon Platform originated over $425 million in new loans, including a record-high $297 million for the HRZN portfolio.”

“In addition, the committed backlog originated by the Horizon Platform grew to $153 million of debt investments, including $125 million in HRZN commitments, while the Horizon Platform maintained a considerable pipeline of new investment opportunities at the end of 2021,” added Mr. Michaud. “This positions the Horizon Platform and HRZN for additional growth in 2022 and further evidences the increasing power of the Horizon brand to attract unique, diverse and transformative companies.”

“Also in the fourth quarter, HRZN received $55 million in loan prepayments – validating our predictive pricing strategy and providing HRZN with additional fee income and accelerated interest income. Entering 2022, we are excited by the opportunity to further grow the Horizon Platform and HRZN loan portfolio and to deliver more value to HRZN’s shareholders,” concluded Mr. Michaud.

Fourth Quarter 2021 Portfolio Update

Originations

During the fourth quarter of 2021, a total of $118.2 million of loans funded through the Horizon Platform, including 17 loans totaling $79.9 million funded by HRZN as follows:

  • $12.5 million to a new portfolio company, Interior Define, Inc., an e-commerce platform that designs, sells and markets customized furniture direct to consumers.
  • $8.5 million to an existing portfolio company, Branded Online, Inc. (d/b/a Nogin), a company offering commerce-as-a-service to consumer and lifestyle brands.
  • $7.5 million to a new portfolio company, GreenLight Biosciences, Inc., a biopharmaceutical company focused on developing ribonucleic acid (RNA) solutions for human health and agricultural challenges.
  • $7.5 million to a new portfolio company, IMV Inc. (NASDAQ: IMV), a clinical-stage biopharmaceutical company developing a new class of cancer immunotherapies and infectious disease vaccines.
  • $7.0 million to a new portfolio company, an online platform offering high quality used cars to consumers on a subscription basis.
  • $5.0 million to a new portfolio company, a builder of conservation memorial forests that offer sustainable alternatives to cemeteries.
  • $5.0 million to an existing portfolio company, Emalex Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system movement disorders and fluency disorders.
  • $5.0 million to an existing portfolio company, Supply Network Visibility Holdings LLC (d/b/a Everstream Analytics), a provider of supply chain risk management software.
  • $5.0 million to an existing portfolio company, Provivi, Inc., a developer of cost-effective natural crop protection products which utilize pheromones to disrupt the typical insect mating cycle.
  • $5.0 million to an existing portfolio company, Ceribell, Inc., a developer of an FDA-cleared rapid response electroencephalography (EEG) medical device, which measures the amount of electrical activity in different regions of the brain in order to diagnose seizures.
  • $3.5 million to a new portfolio company, a family experience creator that combines play, media and merchandise designed to inspire and engage families.
  • $2.5 million to an existing portfolio company, a developer of technology that can identify microbes in order to accelerate treatment and improve public health.
  • $2.5 million to a new portfolio company, a data platform that enables marketers to build personalized digital experiences and 1-to-1 marketing campaigns by focusing on behavioral data.
  • $1.25 million to an existing portfolio company, Unagi, Inc., a developer of premium portable electric scooters that are offered for sale and on an affordable monthly subscription program.
  • $1.0 million to an existing portfolio company, Alula, Inc., a designer and manufacturer of security systems sold exclusively to professional distributors and dealers.
  • $1.0 million to an existing company, InfoBionic, Inc., a developer of an FDA-cleared SaaS remote monitoring system to help treat cardiac arrhythmia.

Liquidity Events

HRZN experienced liquidity events from seven portfolio companies in the fourth quarter of 2021, including principal prepayments of $55.0 million and receipt of warrant and equity proceeds totaling $0.4 million, compared to $50.4 million of principal prepayments and $1.6 million of warrant proceeds during the third quarter of 2021: 

  • In October, Getaround, Inc. prepaid its outstanding principal balance of $25.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee.  HRZN continues to hold warrants in the company.
  • In October, Topia Mobility, Inc. prepaid its outstanding principal balance of $10.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee.  HRZN continues to hold warrants in the company.
  • In October, HRZN received warrant proceeds of $0.1 million from its investment in Education Elements, Inc.
  • In November, CVRx, Inc. prepaid its outstanding principal balance of $20.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee.  HRZN continues to hold warrants in the company.
  • In November, MVI (ABC), LLC (assignee of Stereovision Inc.) paid its outstanding principal balance of $3.5 million on its venture loan, plus interest. 
  • In December, HRZN received $7.0 million from the sale of its debt investment in Betabrand Corporation.  
  • In December, HRZN received cash proceeds of $0.3 million from the sale of shares in Qualtrics International Inc., which HRZN received in connection with the sale of Clarabridge, Inc.

Principal Payments Received

During the fourth quarter of 2021, HRZN received regularly scheduled principal payments on investments totaling $2.9 million, compared to regularly scheduled principal payments totaling $3.2 million during the third quarter of 2021.

Commitments

During the quarter ended December 31, 2021, HRZN closed new loan commitments totaling $114.9 million to 10 companies, compared to new loan commitments of $91.0 million to 11 companies in the third quarter of 2021. HTFM’s other managed funds, during the quarter, closed new loan commitments totaling $38.8 million of unfunded loan approvals and commitments.

Pipeline and Term Sheets

As of December 31, 2021, HRZN’s unfunded loan approvals and commitments (“Committed Backlog”) were $124.5 million to 23 companies. This compares to a Committed Backlog of $100.6 million to 21 companies as of September 30, 2021. HRZN’s portfolio companies have discretion whether to draw down such commitments and the right of a portfolio company to draw down its commitment is often subject to achievement of specific milestones and other conditions to borrowing.  Accordingly, there is no assurance that any or all of these transactions will be funded by HRZN. HTFM’s other managed funds ended the quarter with a total of $28.0 million of unfunded loan approvals and commitments.

During the quarter, HTFM received signed term sheets that are in the approval process, which may result in the Horizon Platform providing up to an aggregate of $135 million of new debt investments.  These opportunities are subject to underwriting conditions including, but not limited to, the completion of due diligence, negotiation of definitive documentation and investment committee approval, as well as compliance with HTFM’s allocation policy. Accordingly, there is no assurance that any or all of these transactions will be completed or funded by HRZN.

Capital Markets Activity – Warrant and Equity Portfolio

As of December 31, 2021, HRZN held a portfolio of warrant and equity positions in 77 portfolio companies, including 64 private companies, which provides the potential for future additional returns to HRZN’s shareholders.

About Horizon Technology Finance

Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of HRZN is to maximize its investment portfolio’s return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon Technology Finance Management LLC is headquartered in Farmington, Connecticut, with a regional office in Pleasanton, California, and investment professionals located in Portland, Maine, Austin, Texas, and Reston, Virginia. To learn more, please visit www.horizontechfinance.com.

Forward-Looking Statements

 Statements included herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Horizon’s filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts:

Investor Relations:
ICR
Garrett Edson
[email protected]
(860) 284-6450

Media Relations:
ICR
Chris Gillick
[email protected] 
(646) 677-1819

SOURCE Horizon Technology Finance Corporation

Posted on

Novo Seeds Provides Business Update on a Record Year

– About US$ 550 million lifted by portfolio businesses in 2021

– IO Biotech IPO on US NASDAQ

– Forendo Pharma obtained for just about US$ 1 billion

– Muna released with world-main science to progress most up-to-date scientific breakthroughs in neuroscience

– Adcendo elevated US$ 60 million Sequence A to deliver following-generation Antibody-Drug Conjugates

– Hemab elevated US$ 50 million Sequence A to acquire bispecific antibodies for the procedure of rare bleeding conditions

– Novo Seeds expanded its bioindustrials portfolio with Bactolife and 21st Bio

COPENHAGEN, Denmark, Jan. 12, 2022 /PRNewswire/ — Novo Seeds, the early stage investment and company development crew of Novo Holdings, now publishes its review of 2021 – an exceptional yr for enterprise generation and the portfolio. For more information, please see in this article.

Novo Seeds’ dedication to early-stage funding and undertaking creation resulted in an unparalleled amount of capital and curiosity from fellow VCs throughout Europe and the US in 2021, with above US$ 550 million raised by Novo Seeds’ portfolio organizations. Targeted on maximising the prospective of scientific breakthroughs, Novo Seeds ongoing to see an growing range of thrilling financial investment possibilities. Muna Therapeutics, Adcendo and Hemab, a few providers that Novo Seeds helped create, every single elevated sizeable Series A rounds in excessive of US$ 50 million. Meanwhile, 2021 observed the NASDAQ IPO of IO Biotech, a portfolio organization for which Novo Seeds was the 1st trader and continued to be a main investor during the firm’s advancement and progress. Pharma M&A was a big topic in 2021 with portfolio firm, Forendo Pharma, staying obtained by Organon for US$ 954 million, but yet another example of Nordic price development.

Commenting on a hugely profitable calendar year, Søren Møller, Controlling Companion at Novo Seeds, claimed: “2021 has shown the enormous prospective of our industry to translate scientific breakthroughs into greater therapies addressing significant world unmet clinical requirements. Novo Seeds gained a by no means-viewed-ahead of volume of money and fascination from European and US buyers, and we are very pleased to have co-led new investments with extraordinary fellow VCs and to have labored with experts and founders across the most renowned tutorial establishments in the Nordics and all-around the environment.”

“Our ambition proceeds to be to nurture and incubate untapped innovation in the Nordic region and globally, with the intention of constructing and facilitating synergistic collaborations across the lifetime science ecosystem, and we are uniquely positioned to do this. 2021 was definitely a document calendar year and we anticipate a lot more thrilling company creation and substantial developments across our portfolio in 2022.”

Novo Seeds’ knowledge in constructing biotech corporations, alongside one another with its monetary sources, network, and group of business people-in-residence, will make it a person of the major venture creators in Europe. The crew can help build lifestyle science ventures to real inflection factors, attracting international traders to considerable financing rounds and supporting portfolio companies in productive exits.

About Novo Holdings A/S

Novo Holdings A/S is a non-public minimal liability firm wholly owned by the Novo Nordisk Basis. It is the keeping corporation of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is dependable for controlling the Novo Nordisk Foundation’s property.

Novo Holdings is recognized as a primary intercontinental daily life science investor, with a target on creating lengthy-phrase value. As a daily life science trader, Novo Holdings presents seed and undertaking funds to enhancement-stage organizations and normally takes considerable ownership positions in growth and properly-set up providers. Novo Holdings also manages a wide portfolio of diversified economical belongings. Even more info: www.novoholdings.dk.

Cision

Cision

View initial information:https://www.prnewswire.com/information-releases/novo-seeds-offers-business-update-on-a-history-calendar year—developing-excellent-organizations-for-world wide-effects-301459252.html

Supply Novo